Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2333-2338

  Abruzzo, George K ^a   Flattery, Amy M ^a   Gill, Charles J ^a   Kong, Li ^a   Smith, Jeffrey G ^a   Pikounis, V Bill ^a   Balkovec, J M ^a   Bouffard, A F ^a   Dropinski, J F ^a   Rosen, Hugh ^a   Kropp, Helmut ^a   Bartizal, Ken ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDIASIS; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030665045     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2333     Document Type: Article

References (40)

1. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, D. Krupa, V. B. Pikounis, H. Kropp, and K. Bartizal. 1995. Evaluation of water soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 39:1077-1081.
2. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Pikounis, H. Kropp, H. Rosen, and K. Bartizal. 1996. Evaluation of water soluble pneumocandin L-743,872 in mouse models of disseminated aspergillosis, candidiasis and cryptococcosis, abstr. F37, p. 106. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Abruzzo, G. K., A. Flattery, C. Gill, J. Smith, H. Kropp, and K. Bartizal. 1993. Evaluation of water soluble lipopeptides in a mouse model of disseminated aspergillosis, abstr. 355, p. 184. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Balkovec, J. M., R. M. Black, G. K. Abruzzo, K. Bartizal, S. Dreikorn, and K. Nollstadt. 1993. Pneumocandin antifungal lipopeptides. The phenolic hydroxyl is required for 1,3-β-o-glucan synthesis inhibition. Bioorg. Med. Chem. Lett. 3:2039-2042.
5. Bartizal, K., G. Abruzzo, and D. Schmatz. 1993. The pneumocandins: biological activity of the pneumocandins, p. 421-455. In J. Rippon and R. A. Fromtling (ed.), Cutaneous fungal infections. Marcel Dekker, Inc., New York, N.Y.
6. Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332.
7. Bartizal, K., A. Flattery, L. Lynch, C. Pacholok, C. J. Gill, H. Rosen, and H. Kropp. 1996. In vitro preclinical evaluation studies with pneumocandin antifungal L-743872, abstr. F32. p. 105. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Bartizal, K., T. Scott, G. K. Abruzzo, C. J. Gill, C. Pacholok, L. Lynch, and H. Kropp. 1995. In vitro evaluation of penumocandin antifungal L-733560, a new water soluble hybrid of L-705589 and L-731373. Antimicrob. Agents Chemother. 39:1070-1076.
9. Bernard, E. M., T. Ishimaru, and D. Armstrong. 1996. Low doses of the pneumocandin, L-743,872, are effective for prevention and treatment in an animal model of pulmonary aspergillosis, abstr. F39, p. 106. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Bernard, E. M., F. F. Edwards, D. Armstrong, and M. B. Kurtz. 1993. Activity of the three pneumocandins in an animal model of pulmonary aspergillosis, abstr. 354, p. 184. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. O derivatives. J. Med. Chem. 37:222-225.
12. Bouffard, F. A., J. F. Dropinski, J. M. Balkovec, R. M., Black, M. L. Hammond, K. H. Nollstadt, and S. Dreikorn. 1996. L-743,872, a novel antifungal lipopeptide: Synthesis and structure-activity relationships of new aza-substituted pneumocandins, abstr. F27, p. 104. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Chin, N. X., I. Weitzman, and P. Della-Latta. 1996. A study of in vitro antifungal activity of L-743,872 against Fusarium, Rhizopus and Trichosporon species, abstr. F34, p. 105. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Current, W. L., C. J. Boylan, and P. P. Raab. 1993. Anti-Pneumocystis activity of LY303336 and other echinocandin B analogs, abstr. 368, p. 186. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Del Poeta, M., W. A. Schell, and J. Perfect. 1996. In vitro antifungal activity of L-743,872 against a variety of moulds, abstr. F33, p. 105. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Draper, N., and H. Smith. 1981. Applied regression analysis. John Wiley & Sons, Inc., New York, N.Y.
17. Espinel-Ingroff, A. 1996. In vitro studies with L-743,872, a water soluble pneumocandin: a comparative study, abstr. F31, p. 105. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Fisher, R. A. 1935. The design of experiments. Oliver and Boyle, Edinburgh, United Kingdom.
19. + T-cell deficient mouse model for oropharyngeal and gastrointestinal candidiasis, abstr. F40, p. 106. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Fothergill, A. W., D. A. Sutton, and M. G. Rinaldi. 1996. Antifungal susceptibility testing of Merck L-743,872 against a broad range of fungi, abstr. F29, p. 105. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
21. Franzot, S. P., and A. Casadevall. 1996. In vitro synergy of pneumocandin L-743,872 with fluconazole and amphotericin B against Cryptococcus neoformans, abstr. F36, p. 106. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Hajdu, R., R. Thompson, J. G. Sundelof, B. A. Pelak, F. A. Bouffard, J. F. Dropinski, and H. Kropp. 1997. Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrobial. Agents Chemother. 41:2339-2344.
23. Hajdu, R., B. Pelak, J. Sundelof, R. Thompson, H. Rosen, and H. Kropp. 1996. Pharmacokinetics of L-743,872 in the mouse, rat, rhesus and chimpanzee, abstr. F44, p. 107. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
24. Kaplan, E. L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 53:457-481.
25. Knudson, L. F., and J. M. Curtis. 1947. The use of the angular formulation in biological assays. J. Am. Statist. Soc. 42:282-296.
26. Kurtz, M. B., C. Douglas, J. Marrinan, K. Nollstadt, J. Onishi, S. Dreikorn, J. Milligan, S. Mandala, J. Thompson, J. M. Balkovec, F. A. Bouffard, J. F. Dropinski, M. L. Hammond, R. A. Zambias, G. Abruzzo, K. Bartizal, O. B. McManus, and M. L. Garcia. 1994. The increased antifungal activity of L-733560, a water soluble semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob. Agents Chemother. 38:2750-2757.
27. Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikorn, and C. Douglas. 1994. Morphological effects of pneumocandins against Aspergillus fumigatus correlate with activity against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
28. Merck & Co. May 21, 1996. Press release, business wire. Data on file. Merck & Co., White House Station, N.J.
29. Morgan, B. J. T. 1992. The analysis of quantal response data. Chapman & Hall, London, United Kingdom.
30. Najvar, L., A. Fothergill, M. Luther, and J. Graybill. 1996. Efficacy of L-743,872 (872) in murine disseminated candidiasis, abstr. F38, p. 106. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
31. Najvar, L., J. Graybill, E. Montalbo, F. Barchiesi, and M. Luther. 1996. Evaluation of L-743,872 (872) in the treatment of murine histoplasmosis, abstr. F43, p. 107. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
32. Nelson, P. W., M. Lozano-Chiu, and J. H. Rex. 1996. In vitro activity of L-743,872 against putatively amphotericin B (AmB) and fluconazole (Flu)-resistant Candida isolates, abstr. F28, p. 104. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
33. Pacholok, C., L. Lynch, H. Kropp, and K. Bartizal. 1993. In vitro evaluation of L-733,560, a new water soluble lipopeptide hybrid of L-705,589 and L-731,373, abstr. 351, p. 184. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
34. Powles, M. A., J. Anderson, P. Liberator, and D. M. Schmatz. 1996. Efficacy of semisynthetic pneumocandin analog L-743,872 against Pneumocystis carinii in murine models, abstr. F42, p. 107. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
35. Pregibon, D. 1982. Resistant fits for some commonly used logistic models with medical applications. Biometrics 38:485-498.
36. Schmatz, D., D. C. McFadden, P. Liberator, J. Anderson, and M. A. Powles. 1993. Evaluation of new semisynthetic pneumocandins against Pneumocystis carinii in the immunocompromised rat, abstr. 356, p. 184. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
37. Schmatz, D. M., G. Abruzzo, M. A. Powles, D. C. McFadden, J. M. Balkovec, R. M. Black, K. Nollstadt, and K. Bartizal. 1992. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species. J. Antibiot. 45:1886-1891.
38. Smith, J. G., G. K. Abruzzo, C. J. Gill, A. M. Flattery, L. Kong, H. Rosen, H. Kropp, and K. Bartizal. 1996. Evaluation of pneumocandin L-743,872 in neutropenic mouse models of disseminated candidiasis and aspergillosis, abstr. F41, p. 107. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
39. Vasquez, J. A., D. Boikov, M. E. Lynch, and J. D. Sobol. 1996. In vitro antifungal activity of L-743,872, a new pneumocandin, against sensitive and resistant Torulopsis and Candida species, abstr. F30, p. 105. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
40. Vasquez, J. A., M. T. Arganoza, P. Steffan, and R. A. Atkins. 1996. In vitro susceptibility of L-743,872 (L), a new pneumocandin, combined with commonly used antifungals against Candida and Torulopsis species, abstr. F35, p. 106. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.